Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aspire-Lakewood HoldingsASBP +2.42%11 Days Payable is 897.78 as of Jun. 2026, which is 98% below its 10-year median of 40,271.67. GuruFocus rates ASBP with a GF Score™ of 11/100. The stock has 2 warning signs investors should review. Among 708 Biotechnology companies, Aspire-Lakewood Holdings ranks better than 92.94% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Aspire-Lakewood Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aspire-Lakewood Holdings Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Aspire-Lakewood Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Aspire-Lakewood Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Aspire-Lakewood Holdings's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aspire-Lakewood Holdings (ASBP) has a Days Payable of 897.78 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Aspire-Lakewood Holdings and its competitors. This is 98% below median its historical median of 40,271.67. Over the past decade, Aspire-Lakewood Holdings' Days Payable has ranged from 3,171.58 to 40,271.67. According to the industry distribution chart, Aspire-Lakewood Holdings ranks #50 out of 708 companies in the Biotechnology industry, placing it in the top 7.1%.
Is Aspire-Lakewood Holdings' Days Payable too high?
Aspire-Lakewood Holdings' current Days Payable of 897.78 is 98% below median its 10-year median of 40,271.67. Over the past 10 years, this metric has ranged from a low of 3,171.58 to a high of 40,271.67. The Biotechnology industry median Days Payable is 111.42. Aspire-Lakewood Holdings' value of 897.78 is 705.8% above this industry median. Based on the distribution chart, Aspire-Lakewood Holdings ranks #50 out of 708 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Aspire-Lakewood Holdings has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Aspire-Lakewood Holdings' Days Payable compare to PDSB and KPRX?
According to the Biotechnology industry distribution chart, Aspire-Lakewood Holdings ranks #50 out of 708 companies for Days Payable. This places Aspire-Lakewood Holdings in the top 7% of its industry — outperforming the majority of peers. The industry median Days Payable is 111.42. Aspire-Lakewood Holdings' value of 897.78 is 705.8% above this benchmark. Historically, Aspire-Lakewood Holdings' own Days Payable has ranged from 3,171.58 to 40,271.67 over the past decade. While the company's 10-year median is 40,271.67 vs. the industry median of 111.42, Aspire-Lakewood Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 111.42, based on 708 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aspire-Lakewood Holdings's current Days Payable of 897.78 is 705.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Aspire-Lakewood Holdings and its competitors. For the Biotechnology industry, the median Days Payable is 111.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aspire-Lakewood Holdings's current Days Payable is 897.78, which is 98% below median its own 10-year median of 40,271.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspire-Lakewood Holdings stock overvalued right now?
Aspire-Lakewood Holdings (ASBP) has a current Days Payable of 897.78. The current Days Payable is 897.78, which is 98% below median its 10-year median of 40,271.67 and 705.8% above the Biotechnology industry median of 111.42. Aspire-Lakewood Holdings' overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Aspire-Lakewood Holdings (ASBP), the current Days Payable is 897.78 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
11GF Score
Get the complete analysis for ASBP
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASBP has been successfully added to your 
